Nov 29
2024 Medical Device Recalls
Medical Devices, Radiation-Emitting Products
For Health Professionals
FDA Collaborates with Health Professional Societies, Trade Associations, and Academia
Topic Paragraphs
Call-To-Action Title
Clinicians Connect: Conversations with FDA's Chief Medical Officer on Overdose Prevention
Call-To-Action Title
Clinicians Connect: Conversations with FDA's Chief Medical Officer on Overdose Prevention
September 25, 2024 - Clinicians hear directly from the FDA, SAMHSA, NIH and AHRQ about the latest in overdose prevention.
Learn More
Subscribe to our e-newsletter
We know you're busy! The easiest way to keep up with us is to subscribe to our weekly e-newsletter.
You'll get the latest announcements, regulations, and upcoming events delivered to your email inbox every Monday.
How to Report Adverse Events to FDA MedWatch
Health professionals, consumers and patients can voluntarily report observed or suspected adverse events for human medical products to FDA. Voluntary reporting can help FDA identify unknown risk for approved medical products.
Learn More
Clinicians Connect: Conversations with FDA's Chief Medical Officer
Join FDA’s Chief Medical Officer for a clinically focused conversation that will cover a different topic each meeting. For more information, subscribe to our mailing list.
Subscribe to the Clinicians Connect mailing listMedWatch Safety Alerts
Nov 29
Hemodialysis Correction: Baxter Issues Correction for AK 98 Hemodialysis Machines Due to Risk of Patient Exposure to Higher Than Allowable Levels of Toxic Compound NDL-PCBA and/or NDL-PCBs
Medical Devices
Nov 29
Peritoneal Dialysis Set Correction: Baxter Issues Correction for MiniCap Extended Life Peritoneal Dialysis Transfer Sets Due to Risk of Patient Exposure to Higher Than Allowable Levels of Toxic Compound NDL-PCBA and/or NDL-PCBs
Medical Devices
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Upholding Public Trust: FDA Office of Criminal Investigations’ Crucial Role in Bringing Drug Criminals to Justice
OCI investigators have been conducting and coordinating criminal investigations of suspected illegal activities involving FDA-regulated products.
One Health - Optimal Public Health Outcomes for Humans and Animals in Our Shared Environment
FDA collaborates with stakeholders across disciplines and sectors to promote the health of humans, animals, and the environment.
FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub
The Hub will act as the single point of engagement and connection with outside parties for drug and biological product development.
Reach out today to talk about collaborating!
Public Engagement Staff
Office of External Affairs
Office of the Commissioner
Food and Drug Administration
10903 New Hampshire Ave WO32-5367
Silver Spring, MD 20993
United States
Office of External Affairs
Office of the Commissioner
Food and Drug Administration
10903 New Hampshire Ave WO32-5367
Silver Spring, MD 20993
United States
Hours Available
Public Engagement Staff
Paragraph Header (Column 2)
MedWatch Safety Alerts on X:
Paragraph Header (Column 2)
MedWatch Safety Alerts on X:
MedWatch
FDA MedWatch Safety Information
You know the moment it happens.
Follow @FDAMedWatch